KR950032177A - 5-비닐- 및 5-에티닐-퀴놀론-및-나프티리돈-카르복실산 - Google Patents
5-비닐- 및 5-에티닐-퀴놀론-및-나프티리돈-카르복실산 Download PDFInfo
- Publication number
- KR950032177A KR950032177A KR1019950004888A KR19950004888A KR950032177A KR 950032177 A KR950032177 A KR 950032177A KR 1019950004888 A KR1019950004888 A KR 1019950004888A KR 19950004888 A KR19950004888 A KR 19950004888A KR 950032177 A KR950032177 A KR 950032177A
- Authority
- KR
- South Korea
- Prior art keywords
- methyl
- represents hydrogen
- hydrogen
- alkyl
- hydroxyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3526—Organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3544—Organic compounds containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Quinoline Compounds (AREA)
Abstract
본 발명은 신규한 5-비닐-및 5-에티닐-퀴놀론-및-나프티리돈카르복실산, 이의 제조 방법, 및 이들을 함유하는 항균 조성물 및 사료 첨가제에 관한 것이다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (16)
- 하기 일반식(I)의 퀴놀론-및 나프티리돈-카르복실산 유도체 및 이의 제약상 허용되는 수화물 및 산부가염, 및 알칼리 금속염, 알칼리토금속염, 은염 및 구아니디늄염.상기 식에서, R1은 히드록실, 할로겐 또는 C1-C3-알콕시에 의해 임의로 치환된 직쇄 또는 분지쇄 C1-C4-알킬, 또는 할로겐 또는 C1-C3-알킬에 의해 임의로 치환된 C3-C6-시클로알킬, 또는 C2-C4-알케닐, 또한 C1-C|3-알콕시, 아미노, 탄소 원자수가 1 내지 3인 모노알킬아미노, 탄소 원자수가 2 내지 6인 디알킬아미노, 또는 할로겐에 의해 임의로 일-내지 삼치환된 페닐을 나타내고, R2는 수소, 탄소 원자수가 1 내지 4인 알킬 또는 (5-메틸-2-옥소1,3-디옥솔-4-일)-메틸을 나타내고, X는 CH, C-할로겐, COCH3, COCHF2, C-CH3또는 N기를 나타내고, Z는또는 -C≡C-R5-(상기 식에서, R3는 수소, C1-C3-알킬, C1-C3-알콕시 또는 알콕시 부분 중 탄소 원자수가 1 내지 3인 알콕시메틸을 나타내고, R4수소 또는 할로겐을 나타내며, R5는 수소, 할로겐 또는 히드록실에 의해 임의로 일-내지 삼치환된 C1-C6-알킬, 또는 C2-C3-알케닐, 탄소 원자수가 1 내지 3인 알콕시, 알콕시 부분 중 탄소 원자수가 1 내지 3인 알콕시메틸, 할로겐 또는 트리메틸실릴을 나타냄)을 나타내고, Y는(상기 식에서, R6은 수소, 히드록실 또는 메톡시에 의해 임의로 치환된 직쇄 또는 분지쇄 C1-C4-알킬, 또는 시클로프로필, 탄소 원자수가 1 내지 4인 옥소알킬, 또는 탄소 원자수가 1 내지 3인 아실을 나타내고, R7은 수소, 메틸, 페닐, 티에닐 또는 피리딜을 나타내고, R8은 수소 또는 메틸을 나타내고, R9는 수소 또는 메틸을 나타내고, R10은 수소 또는 메틸을 나타내고, R11은 수소, 메틸 또는을 나타내고 R12는 수소, 메틸, 아미노, 알킬 부분 중 탄소 원자수가 1 또는 2이고 히드록실에 의해 임의로 치환된 알킬-또는 디알킬아미노메틸, 또는 1-이미다졸릴을 나타내고, R13은 수소, 히드록실, 메톡시, 메틸티오 또는 할로겐, 메틸, 히드록시메틸을 나타내고, R14는 수소 또는 메틸을 나타내고, R15는 수소, 메틸 또는 에틸을 나타내고, R16은 수소, 메틸 또는 에틸을 나타내고, R17은 수소, 메틸 또는 에틸을 나타내고, R18은 히드록실,또는을 나타내고, R19는 수소, 히드록실에 의해 임의로 치환된 C1-C3-알킬, 알콕시 부분중 탄소 원자수가 1 내지 4인 알콕시카르보닐 또는 C1-C3-아실을 나타내고, R20은 수소, 히드록실 |히드록시메틸 또는(식중, R21은 수소 또는 메틸을 나타냄)을 나타내고, A는 CH2, 0 또는 직접 결합을 나타내며, n은 1 또는 2를 나타냄)을 나타낸다.
- 제1항에 있어서, R1이 임의로 히드록실-또는 할로겐-치환된 C1-C2-알킬, C3-C5-시클로알킬, 비닐, 아미노, 탄소 원자수가 1 또는 2인 모노알킬아미노, 탄소 원자수가 2 내지 4인 디알킬아미노, 또는 할로겐에 의해 임의로 일-또는 이치환된 페닐을 나타내고, R2가 수소, 탄소 원자수가 1 내지 3인 알킬 또는 (5-메틸-2-옥소-1,3-디옥솔-4-일)-메틸을 나타내고, X가 CH, CF, CCl, COCH3또는 N기를 나타내고, Z가또는 -C≡C-R5(상기 식에서, R3는 수소, C1-C2-알킬, 메톡시 또는 메톡시메틸을 나타내고 R4는 수소를 나타내며, R5는 수소, 불소에 의해 임의로 일-내지 삼치환된 C1-C4-알킬, 또는 C2-C3-알케닐, 메톡시 또는 트리메틸실릴을 나타냄)을 나타내고, Y가또는(상기 식에서, R6은 수소, 히드록실에 의해 임의로 치환된 직쇄 또는 분지쇄 C1-C3-알킬, 또는 탄소 원자수가 1 내지 4인 옥소알킬을 나타내고, R7은 수소, 메틸 또는 페닐을 나타내고, R8은 수소 또는 메틸을 나타내고, R9는 수소 또는 메틸을 나타내고, R11은 수소, 메틸 또는 -CH2-NH2를 나타내고, R12는 수소, 메틸, 아미노, 메틸아미노, 디메틸아미노, 아미노메틸, 메틸아미노메틸 또는 에릴아미노메틸을 나타내고, R13은 수소, 히드록실, 메톡시, 불소, 메틸 또는 히드록시메틸을 나타내고, R15는 수소 또는 메틸을 나타내고, R16은 수소 또는 메틸을 나타내고, R17은 수소 또는 메틸을 나타내고, R18은또는을 나타내고, R19는 수소, 메틸 또는 에틸을 나타내고, R20은(상기 식에서, R21은 수소 또는 메틸을 나타냄)을 나타내고, A는 CH2, 0 또는 직접 결합을 나타내며, n은 1 또는 2를 나타냄)을 나타내는 퀴놀론- 및 나프티리돈-카르복실산 유도체.
- 제1항에 있어서, R1이 메틸, 에틸, 시클로프로필, 플루오로시클로프로필, 또는 불소에 의해 임의로 일- 또는 이치환된 페닐을 나타내고, R2가 수소, 메틸 또는 에틸을 나타내고, X가 CH, CF, 또는 CCl을 나타내고, Z가 -CH≡CH2또는 -C≡C-R5(상기 식에서, R5는 수소 또는 트리메틸실릴을 나타냄)을 나타내고, Y가(상기 식에서, R6은 수소, 히드록실에 의해 임의로 치환된 메틸 또는 에틸을 나타내고, R7은 수소, 메틸을 나타내고, R8은 수소 또는 메틸을 나타내고, R9는 수소 또는 메틸을 나타내고, R11은 수소 또는 -CH2-NH2를 나타내고, R12는 수소, 메틸, 아미노, 메틸아미노, 아미노메틸 또는 에릴아미노메틸을 나타내고, R13은 수소, 히드록실 또는 메톡시를 나타내고, R15는 수소 또는 메틸을 나타내고, R16은 수소 또는 메틸을 나타내고, R17은 수소 또는 메틸을 나타내고, R18은을 나타내고, R19는 수소 또는 메틸을 나타내고,(상기 식에서, R21은 수소 또는 메틸을 나타냄)을 나타내고, A는 CH2, 0 또는 직접 결합을 나타내며, n은 1을 나타냄)을 나타내는 퀴놀론- 및 나프티리돈-카르복실산 유도체.
- 하기 일반식(Ⅱ)의 퀴놀론- 및 나프티리돈-카르복실산 유도체.상기 식에서, R1, R2, X 및 Z는 제1항에서 정의한 바와 같고, B는 할로겐, 특히 불소 또는 염소를 나타낸다.
- 하기 일반식(Ⅱ)의 화합물을 하기 일반식(Ⅲ)의 화합물과 필요하다면 산제거제의 존재하에 반응시키는 것을 특징으로 하는, 제1항에 따른 퀴놀론- 및 나프티리돈-카르복실산 유도체의 제조 방법.상기 식에서, R1, R2, X, Y 및 Z는 제1항에서 정의한 바와 같고, B는 할로겐, 특히 불소 또는 염소를 나타낸다.
- 전이 금속 촉매의 존재하에, 하기 일반식(Ⅳ)의 화합물을 하기 일반식(Ⅴ)의 유기 금속 비닐 또는 알키닐 화합물과 반응시키고, 필요한 경우 존재하는 보호기를 제거하는 것을 특징으로 하는, 제1항에 따른 퀴놀론- 및 나프티리돈-카르복실산 유도체의 제조 방법.상기 식에서, R1, R2, X, Y 및 Z는 제1항에서 정의한 바와 같고, D는 할로겐, 특히 염소, 브롬 또는 요오드, 또는 OSO2RF기 (여기서, RF는 탄소 원자수가 1 내지 8인 퍼플루오로알킬 라디칼을 나타냄)을 나타내고, M은 SnR′3, ZnX′또는 B(OR″)2(여기서, R′은 C1-C4-알킬을 나타내고, R″은 수소 또는 C1-C|4-알킬을 나타내고, X′은 브롬 또는 염소를 나타냄)을 나타낸다.
- 전이 금속 촉매의 존재하에, 하기 일반식(Ⅵ)의 화합물을 하기 일반식(Ⅴ)의 유기 금속 비닐 또는 알키닐 화합물과 반응시키고, 필요한 경우 존재하는 보호기를 제거하는 것을 특징으로 하는, 제4항에 따른 퀴놀론- 및 나프티리돈-카르복실산 유도체의 제조 방법.상기 식에서, R1, R2, B, D, M, X 및 Z는 제1항 내지 제6항에서 정의한 바와 같다.
- 1-시클로프로필-6,7,8-트리플루오로-1,4-디히드로-4-옥소-5-비닐-3-퀴놀린카르복실산 및 그의 에스테르.
- 6,7,8-트리플루오로-1-(2,4-디플루오로페닐)-1,4-디히드로-4-옥소-5-비닐-3-퀴놀린카르복실산 및 그의 에스테르.
- 1-시클로프로필-6,7,8-트리플루오로-1,4-디히드로-5-트리메틸실릴에티닐-4-옥소-3-퀴놀린카르복실산 및 그의 에스테르.
- 1-시클로프로필-5-에티닐-6,7,8-트리플루오로-1,4-디히드로-4-옥소-3-퀴놀린카르복실산 및 그의 에스테르.
- 1-시클로프로필-7-(S,S-2,8-디아자비시클로[4.3.0]논-8-일)-6,8-디플루오로-1,4-디히드로-4-옥소-5-비닐-3-퀴놀린카르복실산.
- 7-(3-아미노-피롤리딘-1-일)-1-시클로프로필-6,8-디플루오로-1,4-디히드로-4-옥소-5-비닐-3-퀴놀린카르복실산.
- 인간 및 동물의 질병을 퇴치하기 위한, 제1항 내지 제3항 중 어느 하나의 항에 따른 퀴놀론- 및 나프티리돈-카르목실산 유도체.
- 제1항 내지 제3항 중 어느 하나의 항에 따른 퀴놀론- 및 나프티리돈-카르복실산 유도체를 포함하는 약제.
- 약제의 제조에 있어서, 제1항 내지 제3항 중 어느 하나의 항에 따른 퀴놀론- 및 나프티리돈-카르복실산 유도체의 용도.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4408212A DE4408212A1 (de) | 1994-03-11 | 1994-03-11 | 5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren |
DEP4408212.6 | 1994-03-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR950032177A true KR950032177A (ko) | 1995-12-20 |
Family
ID=6512492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950004888A KR950032177A (ko) | 1994-03-11 | 1995-03-10 | 5-비닐- 및 5-에티닐-퀴놀론-및-나프티리돈-카르복실산 |
Country Status (29)
Country | Link |
---|---|
US (2) | US5578604A (ko) |
EP (1) | EP0671391A1 (ko) |
JP (1) | JPH07285941A (ko) |
KR (1) | KR950032177A (ko) |
CN (1) | CN1111629A (ko) |
AU (1) | AU689189B2 (ko) |
BG (1) | BG62001B1 (ko) |
CA (1) | CA2144231A1 (ko) |
CO (1) | CO4340737A1 (ko) |
CZ (1) | CZ63895A3 (ko) |
DE (1) | DE4408212A1 (ko) |
DZ (1) | DZ1862A1 (ko) |
EE (1) | EE9500020A (ko) |
FI (1) | FI951101A (ko) |
HR (1) | HRP950077A2 (ko) |
HU (1) | HUT72071A (ko) |
IL (1) | IL112936A0 (ko) |
LV (1) | LV11469B (ko) |
MA (1) | MA23475A1 (ko) |
NO (1) | NO950936L (ko) |
NZ (1) | NZ270657A (ko) |
PE (1) | PE33895A1 (ko) |
PL (1) | PL307583A1 (ko) |
RU (1) | RU95103433A (ko) |
SK (1) | SK31695A3 (ko) |
SV (1) | SV1995000012A (ko) |
TN (1) | TNSN95017A1 (ko) |
YU (1) | YU15895A (ko) |
ZA (1) | ZA952008B (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4230804A1 (de) * | 1992-09-15 | 1994-03-17 | Bayer Ag | 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate |
DE4427530A1 (de) * | 1994-08-04 | 1996-02-08 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
US6025154A (en) | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
US6743594B1 (en) | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
DE19652219A1 (de) * | 1996-12-16 | 1998-06-18 | Bayer Ag | Verwendung von 7-(1-Aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl)-chinolon- und naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen |
US6984499B2 (en) * | 1997-10-02 | 2006-01-10 | Idexx Laboratories, Inc. | Method and apparatus for concurrently detecting pathogenic organisms and antimicrobial susceptibility |
US6815438B2 (en) | 1999-12-14 | 2004-11-09 | Neurosearch A/S | Heteroaryl-diazabicycloalkanes |
US7175988B2 (en) | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
US20040147505A1 (en) * | 2001-06-01 | 2004-07-29 | Dan Peters | Novel heteroaryl-diazabicyclo alkanes as cns-modulators |
DE60233728D1 (de) * | 2001-06-06 | 2009-10-29 | Neurosearch As | Kationenleitende gaba-a-rezeptoren und deren verwendung |
US7393934B2 (en) | 2001-12-21 | 2008-07-01 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor (CCR5) HDGNR10 |
JP4639149B2 (ja) | 2003-09-10 | 2011-02-23 | 杏林製薬株式会社 | 7−(4−置換−3−シクロプロピルアミノメチル−1−ピロリジニル)キノロンカルボン酸誘導体 |
EP1723178A4 (en) | 2004-03-12 | 2007-12-12 | Human Genome Sciences Inc | HUMAN G-PROTEIN CHEMOKIN RECEPTOR (CCR5) HDGNR10 |
WO2008143343A1 (ja) | 2007-05-24 | 2008-11-27 | Kyorin Pharmaceutical Co., Ltd. | 14位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体 |
CN103724262B (zh) * | 2013-12-10 | 2016-05-18 | 广东省第二人民医院 | 一种氟喹诺酮银化合物及其制备方法和用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5563138A (en) * | 1987-04-16 | 1996-10-08 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
NO885426L (no) * | 1987-12-11 | 1989-06-12 | Dainippon Pharmaceutical Co | Kinolinderivater, samt fremgangsmaate ved fremstilling derav. |
US4920120A (en) * | 1988-01-25 | 1990-04-24 | Warner-Lambert Company | Antibacterial agents |
FI901201A0 (fi) * | 1989-03-13 | 1990-03-09 | Bristol Myers Squibb Co | Antibakteriella 5-substituerade 1,4-dihydro-4-oxonaftyridin-3-karboxylatderivat och deras framstaellning. |
DE3910663A1 (de) * | 1989-04-03 | 1990-10-04 | Bayer Ag | 5-alkylchinoloncarbonsaeuren |
US5252734A (en) * | 1989-04-03 | 1993-10-12 | Bayer Aktiengesellschaft | Antibacterial 5-alkylquinolonecarboxylic acids |
US5140033A (en) * | 1989-04-03 | 1992-08-18 | Bayer Aktiengesellschaft | Antibacterial 5-alkylquinolonecarboxylic acids |
AU661999B2 (en) * | 1991-05-28 | 1995-08-17 | Daiichi Pharmaceutical Co., Ltd. | Pyridonecarboxylic acid derivative |
-
1994
- 1994-03-11 DE DE4408212A patent/DE4408212A1/de not_active Withdrawn
-
1995
- 1995-02-20 HR HRP4408212.6A patent/HRP950077A2/hr not_active Application Discontinuation
- 1995-02-27 EP EP95102762A patent/EP0671391A1/de not_active Withdrawn
- 1995-03-03 US US08/398,328 patent/US5578604A/en not_active Expired - Fee Related
- 1995-03-06 AU AU13649/95A patent/AU689189B2/en not_active Ceased
- 1995-03-06 PE PE1995263451A patent/PE33895A1/es not_active Application Discontinuation
- 1995-03-06 DZ DZ950026A patent/DZ1862A1/fr active
- 1995-03-06 CO CO95008716A patent/CO4340737A1/es unknown
- 1995-03-08 IL IL11293695A patent/IL112936A0/xx unknown
- 1995-03-08 PL PL95307583A patent/PL307583A1/xx unknown
- 1995-03-08 YU YU15895A patent/YU15895A/sh unknown
- 1995-03-08 EE EE9500020A patent/EE9500020A/xx unknown
- 1995-03-08 NZ NZ270657A patent/NZ270657A/en unknown
- 1995-03-08 CA CA002144231A patent/CA2144231A1/en not_active Abandoned
- 1995-03-09 FI FI951101A patent/FI951101A/fi unknown
- 1995-03-09 BG BG99490A patent/BG62001B1/bg unknown
- 1995-03-09 JP JP7077134A patent/JPH07285941A/ja active Pending
- 1995-03-09 TN TNTNSN95017A patent/TNSN95017A1/fr unknown
- 1995-03-10 SV SV1995000012A patent/SV1995000012A/es unknown
- 1995-03-10 NO NO950936A patent/NO950936L/no unknown
- 1995-03-10 CN CN95102213A patent/CN1111629A/zh active Pending
- 1995-03-10 LV LVP-95-48A patent/LV11469B/lv unknown
- 1995-03-10 HU HU9500728A patent/HUT72071A/hu unknown
- 1995-03-10 ZA ZA952008A patent/ZA952008B/xx unknown
- 1995-03-10 SK SK316-95A patent/SK31695A3/sk unknown
- 1995-03-10 KR KR1019950004888A patent/KR950032177A/ko not_active Application Discontinuation
- 1995-03-10 MA MA23803A patent/MA23475A1/fr unknown
- 1995-03-10 RU RU95103433/04A patent/RU95103433A/ru unknown
- 1995-03-10 CZ CZ95638A patent/CZ63895A3/cs unknown
-
1996
- 1996-05-03 US US08/642,662 patent/US5659038A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
LV11469A (lv) | 1996-08-20 |
BG62001B1 (bg) | 1998-12-30 |
LV11469B (en) | 1996-12-20 |
HU9500728D0 (en) | 1995-04-28 |
HRP950077A2 (en) | 1997-08-31 |
JPH07285941A (ja) | 1995-10-31 |
ZA952008B (en) | 1995-12-11 |
EP0671391A1 (de) | 1995-09-13 |
TNSN95017A1 (fr) | 1996-02-06 |
MA23475A1 (fr) | 1995-10-01 |
CA2144231A1 (en) | 1995-09-12 |
IL112936A0 (en) | 1995-06-29 |
PE33895A1 (es) | 1995-12-15 |
CO4340737A1 (es) | 1996-07-30 |
FI951101A0 (fi) | 1995-03-09 |
BG99490A (en) | 1996-01-31 |
SK31695A3 (en) | 1995-09-13 |
PL307583A1 (en) | 1995-09-18 |
US5659038A (en) | 1997-08-19 |
SV1995000012A (es) | 1995-11-06 |
AU689189B2 (en) | 1998-03-26 |
RU95103433A (ru) | 1997-02-10 |
CN1111629A (zh) | 1995-11-15 |
DE4408212A1 (de) | 1995-09-14 |
YU15895A (sh) | 1998-05-15 |
CZ63895A3 (en) | 1995-11-15 |
NZ270657A (en) | 1997-01-29 |
US5578604A (en) | 1996-11-26 |
FI951101A (fi) | 1995-09-12 |
HUT72071A (en) | 1996-03-28 |
NO950936L (no) | 1995-09-12 |
AU1364995A (en) | 1995-09-21 |
EE9500020A (et) | 1995-12-15 |
DZ1862A1 (fr) | 2002-02-17 |
NO950936D0 (no) | 1995-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR950032177A (ko) | 5-비닐- 및 5-에티닐-퀴놀론-및-나프티리돈-카르복실산 | |
RU2395500C2 (ru) | 2,4-пиримидиндиамины, применяемые в лечении неопластических болезней, воспалительных и иммунных расстройств | |
KR930016421A (ko) | 퀴놀론- 및 나프티리돈-카르복실산 유도체 | |
KR940018380A (ko) | 퀴놀론-및 나프티리돈카르복실산 유도체 | |
CA1340114C (en) | 7-(1-pyrrolidinyl)-3-quinolone-and -naphthyridone-carboxylic acid derivatives, process for their preparation and substituted mono-and bicyclic pyrrolidine derivatives as intermediate products for their preparation, and antibacterial and feed additives containing them | |
KR930002320A (ko) | 8-비닐-및 8-에티닐-퀴놀론-카르복실산 | |
KR880012506A (ko) | 벤조헤테로 사이클릭 화합물 | |
WO2003080580A3 (en) | Quinoline derivatives and their use as 5-ht6 ligands | |
CA2535338A1 (en) | Substituted 1h-imidazo[4,5-c]pyridin-4-amines,1h-imidazo[4,5-c]quinolin -4-amines and 1h-imidazo[4,5-c]naphthyridin-4-amines as immune response modifiers | |
CA2137523A1 (en) | One-pot process for the preparation of 3-quinolonecarboxylic acid derivatives | |
IL88303A (en) | Derivatives of 6-fluoro-7-û4-( (5-methyl-2-oxo-1,3- dioxolen-4-yl)methyl) piperazin-1-ylù-4 (1h)-oxo-1,3-thiazeto(3,2-a) quinoline-3-carboxylic acid | |
RU2011133128A (ru) | Противоопухолевые соединения дигидропиран-2-она | |
KR900018074A (ko) | N-헤테로아릴-4-퀴놀린아민, 이의 제조방법 및 약제로서의 이의 용도 | |
KR940007027A (ko) | 7-이소인돌리닐-퀴놀론 유도체 및 7-이소인돌리닐-나프티리돈 유도체 | |
CA2536429A1 (en) | 7-(4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative | |
CA2238875A1 (en) | Tri-aryl ethane derivatives as pde iv inhibitors | |
ES8207149A1 (es) | Un procedimiento para la pre-paracion de imidazolilfenilami-dinas. | |
WO2000064874A3 (en) | Heterosubstituted pyridine derivatives as pde 4 inhibitors | |
EP0043858A1 (en) | Hetero ring-substituted oxoalkanoic acid derivatives | |
DE3563048D1 (en) | 2-pyridine-thiol derivatives, processes for their preparation and pharmaceutical compositions containing them | |
RU2009117467A (ru) | Новые производные морфина | |
ES510828A0 (es) | "un procedimiento para la preparacion de un derivado de morfolina". | |
WO2005095376A1 (en) | Antiviral agents | |
GR930300124T1 (en) | Bile acid sulfurated derivatives | |
HUP0201255A2 (hu) | Új pirimidin-4-on-származékok, eljárás előállításukra, és az ezeket tartalmazó gyógyászati készítmények |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |